Conquering Diseases

Study of Adding Platinum-Based Therapies to Standard Chemotherapy Care for Ovarian Cancer


Seeking women with ovarian cancer for a study of whether adding investigational drugs to the usual treatment delays or prevents ovarian cancer from coming back


We are comparing whether ovarian cancer comes back when study participants get two investigational drugs, one investigational drug, or no investigational drugs (placebo) added to their chemotherapy for ovarian cancer.

What we're hoping for

We are hoping to assess the safety and effectiveness of adding two different platinum-based therapies to the usual chemotherapy treating ovarian cancer. We hope to find out which combination prevents the cancer from coming back.

Additional Information Identifier: NCT03602859

 Principal Investigator

Susan  Zweizig, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office



UMMHC Memorial Campus

281 Lincoln St. 

Worcester,MA 01605